Robotic medical crash cart eases workload for healthcare teams

Researchers have unveiled a robotic crash cart that uses verbal and visual cues to help healthcare teams access the right tools — fast. 

Around Cornell

SWYM founders want you to dive in to find a date for Valentine’s Day

The founders of SWYM created a platform to allow people to connect at real-life events.

Around Cornell

Discovery illuminates how inflammatory bowel disease promotes colorectal cancer

Research unveiled a chain of immune reactions in the gut driven by a key signaling protein and a surge of white blood cells from the bone marrow.

Designing the future: a Q&A with Harald Haraldsson

Through rapid prototyping and creative experimentation, Harald and his students explore how emerging technologies can reshape the way we interact with both digital and physical environments.

Around Cornell

Rebecca Hann named VP for budget and planning

Hann’s appointment was approved Jan. 12 by the Executive Committee of the Cornell Board of Trustees.

Americans still see opioid overdose as a crisis

Approximately 88% of adults view opioid overdose deaths as a very serious problem with high agreement across political groups, according to a national survey conducted by Weill Cornell Medicine researchers.

Pre-cancerous states identified in seemingly normal aging tissues

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the first time, in a study led by investigators at Weill Cornell Medicine and the New York Genome Center.

Leifer named director of postdoctoral affairs office

The office is moving to Research & Innovation under the vice provost for research to integrate postdoctoral support more closely with Cornell’s research enterprise. The office provides career development and other resources for postdoctoral researchers.

Staff News

Around Cornell

Whole-genome sequencing may optimize PARP inhibitor use

The approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments.